ConductScience.org, home

Paper856436

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.

Cvitkovic E and 4 others. Cancer, 1977. Cited by 234 papers, by iCite.

Cite this record

ConductScience Library. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Papers, record 856436. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856436

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.
PubMed
Journal
Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
234
iCite
Relative citation ratio, by iCite
8.03
iCite
Revised in PubMed
2022-03-17
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cvitkovic EE
2Spaulding JJ
3Bethune VV
4Martin JJ
5Whitmore WFW F

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
MannitolMajor topic
Animals
Bone Marrow
Diuresis
Dogs
Infusions, Parenteral
Injections, Intravenous
Kidney

Source PubMed

Download CSV of topics

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.

PMIDTitleJournalYearIn PapersSource
40465128Guidance on the short hydration method for cisplatin administration.Int J Clin Oncol2025https://conductscience.org/library/papers/40465128PubMed
38564107Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial.Int J Clin Oncol2024https://conductscience.org/library/papers/38564107PubMed
38457231Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.Cancer Med2024https://conductscience.org/library/papers/38457231PubMed
37382749Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.Int J Clin Oncol2023https://conductscience.org/library/papers/37382749PubMed
36964641Bidirectional Intraoperative Chemotherapy Using Cisplatin and Ifosfamide for Intraperitoneal Mesothelioma in Severe Renal Impairment: A Case Report.Am J Case Rep2023https://conductscience.org/library/papers/36964641PubMed
35436142The Effect of Intravenous Mannitol Combined With Normal Saline in Preventing Cisplatin-Induced Nephrotoxicity: A Randomized, Double-Blind, Placebo-Controlled Trial.JCO Glob Oncol2022https://conductscience.org/library/papers/35436142PubMed
33805488Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.Cancers (Basel)2021https://conductscience.org/library/papers/33805488PubMed
32757852Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.Expert Opin Drug Metab Toxicol2020https://conductscience.org/library/papers/32757852PubMed
32740717Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.Int J Clin Oncol2020https://conductscience.org/library/papers/32740717PubMed
32489432Cisplatin-induced renal toxicity in elderly people.Ther Adv Med Oncol2020https://conductscience.org/library/papers/32489432PubMed
31831529Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.BMJ Open2019https://conductscience.org/library/papers/31831529PubMed
30167970Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study.Int J Clin Pharm2018https://conductscience.org/library/papers/30167970PubMed
29770217Analysis of adverse events of renal impairment related to platinum-based compounds using the Japanese Adverse Drug Event Report database.SAGE Open Med2018https://conductscience.org/library/papers/29770217PubMed
29504819Effects of miR-144 on the sensitivity of human anaplastic thyroid carcinoma cells to cisplatin by autophagy regulation.Cancer Biol Ther2018https://conductscience.org/library/papers/29504819PubMed
29503734Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trial.ESMO Open2018https://conductscience.org/library/papers/29503734PubMed
28856465Guidelines for treatment of renal injury during cancer chemotherapy 2016.Clin Exp Nephrol2018https://conductscience.org/library/papers/28856465PubMed
26093520Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.Int J Clin Oncol2016https://conductscience.org/library/papers/26093520PubMed
25789143Protective effect of hydroalcoholic extract of tribulus terrestris on Cisplatin induced renal tissue damage in male mice.Int J Prev Med2015https://conductscience.org/library/papers/25789143PubMed
25472655Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.BMC Pharmacol Toxicol2014https://conductscience.org/library/papers/25472655PubMed
25032734Identification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma.Br J Cancer2014https://conductscience.org/library/papers/25032734PubMed

See all 48 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/856436

GET https://conductscience.org/api/papers/v1/856436/cited_by?page=2